Cargando…

Retraction: Paper “Comparison of Effects of Alendronate and Raloxifene on Lumbar Bone Mineral Density, Bone Turnover, and Lipid Metabolism in Elderly Women with Osteoporosis” by Iwamoto J, et al. [Yonsei Med J 2008;49(1):119-128]

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2018
Materias:	Retraction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725357/ https://www.ncbi.nlm.nih.gov/pubmed/29214794 http://dx.doi.org/10.3349/ymj.2018.59.1.167

Ejemplares similares

Retraction: Paper “Comparison of Effect of Treatment with Etidronate and Alendronate on Lumbar Bone Mineral Density in Elderly Women with Osteoporosis” by Iwamoto J, et al. [Yonsei Med J 2005;46(6):750-758]
Publicado: (2019)

Retraction: Paper “Comparison of the Effects of Alendronate and Alfacalcidol on Hip Bone Mineral Density and Bone Turnover in Japanese Men Having Osteoporosis or Osteopenia with Clinical Risk Factors for Fractures” by Iwamoto J, et al. [Yonsei Med J 2009 Aug;50(4):474-481]
Publicado: (2023)

Retraction: Paper “Efficacy of Oral Etidronate for Skeletal Diseases in Japan” by Iwamoto J, et al. [Yonsei Med J 2005 Jun;46(3):313-320]
Publicado: (2023)

Retraction: Paper “Comparison of the Effect of Vitamin K2 and Risedronate on Trabecular Bone in Glucocorticoid-Treated Rats: A Bone Histomorphometry Study” by Iwamoto J, et al. [Yonsei Med J 2009;50(2):189-194]
Publicado: (2018)

Retraction: Paper “Combined Treatment with Vitamin K(2) and Bisphosphonate in Postmenopausal Women with Osteoporosis” by Iwamoto J, et al. [Yonsei Med J 2003;44(5):751-756]
Publicado: (2019)

Retraction: Paper “Differential Effect of Vitamin K and Vitamin D Supplementation on Bone Mass in Young Rats Fed Normal or Low Calcium Diet” by Iwamoto J, et al. [Yonsei Med J 2004;45(2):314-324]
Publicado: (2019)

Comparison of Effects of Alendronate and Raloxifene on Lumbar Bone Mineral Density, Bone Turnover, and Lipid Metabolism in Elderly Women with Osteoporosis
por: Iwamoto, Jun, et al.
Publicado: (2008)

Effects of the Combination Treatment of Raloxifene and Alendronate on the Biomechanical Properties of Vertebral Bone
por: Diab, Tamim, et al.
Publicado: (2011)

Erratum to “Current Anticoagulant Usage Patterns and Determinants in Korean Patients with Nonvalvular Atrial Fibrillation” by Ha HS, et al. (Yonsei Med J 2020;61(2):120–128.)
Publicado: (2021)

Retraction: Hydrogen Peroxide as an Effective Disinfectant for Pasteurella multocida. Yonsei Med J 2014;55:1152-6
por: Jung, In-Soo, et al.
Publicado: (2016)

Erratum to "Efficacy and Safety of Weekly Alendronate Plus Vitamin D(3) 5600 IU versus Weekly Alendronate Alone in Korean Osteoporotic Women: 16-Week Randomized Trial" by Kim KJ, et al. (Yonsei Med J 2014;55:715-24.)
Publicado: (2014)

Alendronate and Raloxifene Therapy in the Early Period after Hip Fracture
por: Ohishi, Tsuyoshi, et al.
Publicado: (2011)

Combination Therapy of Raloxifene and Alendronate for Treatment of Osteoporosis in Elderly Women
por: Um, Mi Jung, et al.
Publicado: (2017)

Comparative safety and effectiveness of alendronate versus raloxifene in women with osteoporosis
por: Kim, Yeesuk, et al.
Publicado: (2020)

ODP119 Raloxifene use after denosumab discontinuation partially attenuates bone loss in the lumbar spine in postmenopausal osteoporosis
por: Hone, Namki, et al.
Publicado: (2022)

Erratum to “Clinical Experience with the Bentall Procedure: 28 Years” by Joo HC, et al. (Yonsei Med J 2012;53:915-23.)
Publicado: (2017)

Fractures in women treated with raloxifene or alendronate: a retrospective database analysis
por: Foster, Shonda A, et al.
Publicado: (2013)

Erratum to “The Inhibition of Insulin-stimulated Proliferation of Vascular Smooth Muscle Cells by Rosiglitazone Is Mediated by the Akt-mTOR-P70S6K Pathway” by Park S, et al. (Yonsei Med J 2008 Aug;49(4):592-600)
Publicado: (2022)

The Effect of Effervescent and Buffered Alendronate Compared to Conventional Alendronate on Markers of Bone Turnover: A Randomized Non-inferiority Trial
por: Hikmet, Rawan, et al.
Publicado: (2023)

Retraction: Jhin-Soo Pyen, et al. Tic Convulsif Caused by Cerebellopontine Angle Schwannoma. Yonsei Med J 2001; 42:255-7
Publicado: (2008)

Retraction: Human Papillomavirus Type 16 E5 Protein as a Therapeutic Target. Yonsei Med J 2006;47(1):1-14
por: Kim, Sang-Woo, et al.
Publicado: (2011)

Erratum to "Snakebite in Korea: A Guideline to Primary Surgical Management" by Rha JH, et al. (Yonsei Med J 2015;56:1443-8.)
Publicado: (2016)

Erratum to “Network Analysis of Language Disorganization in Patients with Schizophrenia” by Park SC, et al. (Yonsei Med J 2020; 61(8): 726-730.)
Publicado: (2020)

Erratum to "Agmatine Improves Cognitive Dysfunction and Prevents Cell Death in a Streptozotocin-Induced Alzheimer Rat Model" by Song J, et al. (Yonsei Med J 2014;55:689-99.)
Publicado: (2015)

Erratum to “Bone Flap Changes after Cranioplasty Using Frozen Autologous Bone Flaps: A Three-Dimensional Volumetric Reconstruction Study” by Lee JH, et al. (Yonsei Med J 2019 Nov;60(11):1067-1073)
Publicado: (2023)

Retraction: Suat Canbaz et al. Bilateral Popliteal Artery Aneurysms with Rupture and Pseudoaneurysm Formation on the Left. Yonsei Med J 2003;44:159-62
por: Choi, In-Hong
Publicado: (2007)

Erratum to "Prevalence, Incidence, and Factor Concentrate Usage Trends of Hemophiliacs in Taiwan" by Tu TC, et al. (Yonsei Med J 2013;54:71-80.)
Publicado: (2013)

Retraction: Paper “eNOS3 Genetic Polymorphism Is Related to Post-Ablation Early Recurrence of Atrial Fibrillation” by Shim J, et al. [Yonsei Med J 2015 Sep;56(5):1244-1250]
Publicado: (2023)

Erratum to "Assessment of Deceased Donor Kidneys Using a Donor Scoring System" by Bang K, et al. (Yonsei Med J 2010;51:870-876)
Publicado: (2011)

Erratum to "The First Case of Familial Mediterranean Fever Associated with Renal Amyloidosis in Korea" by Koo KY, et al. (Yonsei Med J 2012;53:454-8.)
Publicado: (2012)

Erratum to "Effects of Multiple Drilling on the Ischemic Capital Femoral Epiphysis of Immature Piglets" by Gong SY, et al. (Yonsei Med J 2011;52:809-17.)
Publicado: (2012)

Erratum to "The First Case of Familial Mediterranean Fever Associated with Renal Amyloidosis in Korea" by Koo KY, et al. (Yonsei Med J 2012;53:454-8.)
Publicado: (2012)

Erratum to "Clinical Characteristics and Molecular Genetics Analysis of Korean Patients with GNE myopathy" by Sim JE, et al. (Yonsei Med J 2013;54:578-82.)
Publicado: (2013)

Effects of genistein aglycone in osteoporotic, ovariectomized rats: a comparison with alendronate, raloxifene and oestradiol
por: Bitto, A, et al.
Publicado: (2008)

Effects of combination treatment with alendronate and raloxifene on skeletal properties in a beagle dog model
por: Allen, Matthew R., et al.
Publicado: (2017)

Modeling the Annual Costs of Postmenopausal Prevention Therapy: Raloxifene, Alendronate, or Estrogen-Progestin Therapy
por: Mullins, C. Daniel, et al.
Publicado: (2003)

Effects of short-term combined treatment with alendronate and elcatonin on bone mineral density and bone turnover in postmenopausal women with osteoporosis
por: Iwamoto, Jun, et al.
Publicado: (2009)

Disease Systems Analysis of Bone Mineral Density and Bone Turnover Markers in Response to Alendronate, Placebo, and Washout in Postmenopausal Women
por: Berkhout, J, et al.
Publicado: (2016)

Combination therapy of curcumin and alendronate modulates bone turnover markers and enhances bone mineral density in postmenopausal women with osteoporosis
por: Khanizadeh, Fatemeh, et al.
Publicado: (2018)

Raloxifene Has No Efficacy in Reducing the High Bone Turnover and the Risk of Spontaneous Vertebral Fractures after Denosumab Discontinuation
por: Gonzalez-Rodriguez, Elena, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vv3ha2brd9123llqophibjapj1